Compare Dolby Laboratories, Inc. (DLB) vs EPAM Systems Inc (EPAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs EPAM Systems Inc — how do they compare? Dolby Laboratories, Inc. trades at $58.47 (market cap $5.47B), while EPAM Systems Inc trades at $113.86 (market cap $5.59B). The key difference: Dolby Laboratories, Inc. and EPAM Systems Inc are close in size by market cap, and Dolby Laboratories, Inc. pays a 2.47% dividend while EPAM Systems Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and EPAM Systems Inc for 37 Days on average.
| DLB | EPAM | |
|---|---|---|
Market Cap | $5.47B | $5.59B |
Volume | 691,016 | 551,846 |
Sector | Technology | Technology |
52-Week High | $70.09 | $221.40 |
52-Week Low | $48.51 | $76.04 |
Typical Hold Time | 98 Days | 37 Days |
Enterprise Value | $4.84B | $4.95B |
Dividend Yield | 2.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals despite strong profitability margins. The company maintains robust fundamentals with 87.61% gross margins and consistent earnings beats, though revenue has plateaued around $1.3B. Recent leadership transition to Marc Whitten and expanded Meta partnership for Dolby Atmos/Vision represent key developments. Technical indicators show resistance at $59 with support at $58.
DLB offers stable cash flow generation and dividend income but faces growth challenges with flat revenue. Analyst consensus targets $90.33 (55% upside) with 47% buy ratings, though near-term execution risks and licensing volatility warrant caution. The stock presents value for income investors but requires revenue acceleration for significant appreciation.
EPAM Systems trades at $108.32, down 0.91% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $3.38, beating estimates, and maintains strong profitability with a net margin of 7.15%. Recent news highlights partnerships in cloud security and AI-native revenue growth exceeding 11%.
The stock appears undervalued with a P/E of 14.7 and consensus price target of $119.00, offering potential upside. However, risks include slower North American growth and AI disruption to legacy services. Analyst sentiment is mixed with 59% buy ratings but recent institutional selling adds caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →
